Insider · CIK 0001702287

Sandison Taylor

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001702287

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-09-30	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+167K sh	—	—	166,836
2024-09-11	CDTXCidara Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−924 sh	$11.64	−$10.8K	23,067
2024-03-15	CDTXCidara Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+129K sh	—	—	475,845
2024-03-15	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+236K sh	—	—	235,500
2024-03-11	CDTXCidara Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−20.7K sh	$0.67	−$13.8K	347,095
2023-09-11	CDTXCidara Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−18.8K sh	$0.95	−$17.8K	363,757
2023-03-27	CDTXCidara Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+90K sh	—	—	378,550
2023-03-27	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+180K sh	—	—	180,000
2023-03-13	CDTXCidara Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−7,203 sh	$1.53	−$11K	288,550
2022-09-12	CDTXCidara Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−18.5K sh	$0.68	−$12.7K	291,753
2022-03-31	CDTXCidara Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+50K sh	—	—	306,231
2022-03-31	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+100K sh	—	—	100,000
2021-12-29	CDTXCidara Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+15.6K sh	—	—	256,231
2021-12-29	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10K sh	—	—	12,500
2021-12-29	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−5,600 sh	—	—	6,300
2021-09-30	CDTXCidara Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+151K sh	—	—	236,631
2021-03-31	CDTXCidara Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+700 sh	—	—	82,031
2021-03-17	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+145K sh	—	—	145,000
2020-03-19	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+145K sh	—	—	145,000
2020-02-10	CDTXCidara Therapeutics, Inc.X Exercise of In-Money	Chief Medical Officer	XExercise of In-Money	+6,115 sh	$2.51	+$15.3K	73,331
2020-02-10	CDTXCidara Therapeutics, Inc. · Subscription Rights (right to buy)X Exercise of In-Money	Chief Medical Officer	XExercise of In-Money	−6,115 sh	—	—	0
2020-02-07	CDTXCidara Therapeutics, Inc. · Subscription Rights (right to buy)X Exercise of In-Money	Chief Medical Officer	XExercise of In-Money	−4,594 sh	—	—	0
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−19K sh	—	—	0
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+12.7K sh	—	—	12,667
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−5,000 sh	—	—	0
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+3,333 sh	—	—	3,333
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−20K sh	—	—	0
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+13.3K sh	—	—	13,333
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−55K sh	—	—	0
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+32.6K sh	—	—	32,592
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+4,075 sh	—	—	4,075
2019-09-12	CDTXCidara Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+2,500 sh	—	—	57,222
2019-09-12	CDTXCidara Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+1,400 sh	—	—	58,622
2019-09-12	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,500 sh	—	—	22,500
2019-09-12	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−1,400 sh	—	—	12,600
2019-03-21	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+65K sh	—	—	65,000
2019-01-31	CDTXCidara Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+6,000 sh	—	—	50,722
2019-01-31	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+14K sh	—	—	14,000
2018-03-29	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+70K sh	—	—	70,000
2017-09-18	CDTXCidara Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+15K sh	—	—	40,695
2017-09-18	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+25K sh	—	—	25,000
2017-06-07	CDTXCidara Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+19.3K sh	$5.90	+$114K	25,695
2017-06-06	CDTXCidara Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+656 sh	$5.90	+$3,870.4	6,351
2017-03-31	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+55K sh	—	—	55,000
2010-02-07	CDTXCidara Therapeutics, Inc.X Exercise of In-Money	Chief Medical Officer	XExercise of In-Money	+4,594 sh	$2.51	+$11.5K	67,216

Recent filings

Accepted (ET)
Oct 24
Sandison Taylor0001610618-24-000137
SEC(opens sec.gov)
Sep 134
Sandison Taylor0001610618-24-000125
SEC(opens sec.gov)
Mar 204
Sandison Taylor0001610618-24-000024
SEC(opens sec.gov)
Mar 124
Sandison Taylor0001610618-24-000013
SEC(opens sec.gov)
Sep 134
Sandison Taylor0001610618-23-000088
SEC(opens sec.gov)
Mar 294
Sandison Taylor0001610618-23-000032
SEC(opens sec.gov)
Mar 134
Sandison Taylor0001610618-23-000010
SEC(opens sec.gov)
Sep 134
Sandison Taylor0001610618-22-000079
SEC(opens sec.gov)
Apr 44
Sandison Taylor0001610618-22-000027
SEC(opens sec.gov)
Jan 74
Sandison Taylor0001209191-22-002601
SEC(opens sec.gov)
Oct 44
Sandison Taylor0001610618-21-000093
SEC(opens sec.gov)
Apr 54
Sandison Taylor0001610618-21-000029
SEC(opens sec.gov)
Mar 194
Sandison Taylor0001610618-21-000020
SEC(opens sec.gov)
Mar 234
Sandison Taylor0001209191-20-020755
SEC(opens sec.gov)
Feb 114
Sandison Taylor0001209191-20-008463
SEC(opens sec.gov)

Companies

Cidara Therapeutics, Inc.Chief Medical OfficerCDTX

Address

6310 NANCY RIDGE DR #101

SAN DIEGO, CA, 92121